203 related articles for article (PubMed ID: 17902184)
21. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
Hoffmann D; Jogler C; Wildner O
J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
[TBL] [Abstract][Full Text] [Related]
22. Products of cells cultured from gliomas. VII. Extracellular matrix proteins of gliomas which contain glial fibrillary acidic protein.
McKeever PE; Fligiel SE; Varani J; Castle RL; Hood TW
Lab Invest; 1989 Feb; 60(2):286-95. PubMed ID: 2464718
[TBL] [Abstract][Full Text] [Related]
23. Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment.
Hoffmann D; Wildner O
Cancer Gene Ther; 2007 Jul; 14(7):627-39. PubMed ID: 17479104
[TBL] [Abstract][Full Text] [Related]
24. [The distribution of glial fibrillary acidic protein and protein S-100 in experimental brain tumors in rats].
Khalanskiĭ AS; Shevchenko GM; Berezin VA
Zh Vopr Neirokhir Im N N Burdenko; 1991; (1):19-22. PubMed ID: 1649519
[TBL] [Abstract][Full Text] [Related]
25. Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.
Bortolanza S; Bunuales M; Alzuguren P; Lamas O; Aldabe R; Prieto J; Hernandez-Alcoceba R
Cancer Gene Ther; 2009 Sep; 16(9):703-12. PubMed ID: 19229289
[TBL] [Abstract][Full Text] [Related]
26. Increased apoptosis and reduced replication efficiency of the E3 region-modified dl309 adenovirus in cancer cells.
Hibma MH; Real NC; Wiles A; Dobson-Le D; Dix BR; Wynford-Thomas D; Braithwaite AW; Royds JA
Virus Res; 2009 Oct; 145(1):112-20. PubMed ID: 19576936
[TBL] [Abstract][Full Text] [Related]
27. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
Ulasov IV; Rivera AA; Nettelbeck DM; Rivera LB; Mathis JM; Sonabend AM; Tyler M; Wang M; Douglas JT; Lesniak MS
Int J Oncol; 2007 Nov; 31(5):1177-85. PubMed ID: 17912445
[TBL] [Abstract][Full Text] [Related]
28. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
McKie EA; Graham DI; Brown SM
Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
[TBL] [Abstract][Full Text] [Related]
29. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
30. Expression of glial fibrillary acidic protein in primary cultures of human Müller cells.
Lupien C; Brenner M; Guérin SL; Salesse C
Exp Eye Res; 2004 Sep; 79(3):423-9. PubMed ID: 15336506
[TBL] [Abstract][Full Text] [Related]
31. [Variants of adenovirus type 5 with deletions in early genes: ability for selective replication in p53-defective human tumor cells].
Kachko AV; Sviatchenko VA; Ternovoĭ VA; Kiselev NN; Sorokin AV; Kiselev SL; Georgiev GP; Netesov SV
Mol Biol (Mosk); 2003; 37(5):868-75. PubMed ID: 14593924
[TBL] [Abstract][Full Text] [Related]
32. Inoculation of C6 cell suspension into the brain of adult rats: immunohistochemical study.
Mokrý J; Nĕmecek S; Adler J; Dĕdic K
Funct Dev Morphol; 1993; 3(3):175-80. PubMed ID: 8167397
[TBL] [Abstract][Full Text] [Related]
33. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy.
Wang CY; Li F; Yang Y; Guo HY; Wu CX; Wang S
Cancer Res; 2006 Jun; 66(11):5798-806. PubMed ID: 16740719
[TBL] [Abstract][Full Text] [Related]
34. Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo.
Zamorano A; Mellström B; Vergara P; Naranjo JR; Segovia J
Neurobiol Dis; 2004 Apr; 15(3):483-91. PubMed ID: 15056455
[TBL] [Abstract][Full Text] [Related]
35. [The specific killing of human melanoma cells by replication selective adenovirus].
Xie QJ; Lu YL; Chen ZJ; Zhang JQ; Chen HH; Ling XL; Lü P; Du ZY; Xu YJ
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):448-52. PubMed ID: 14575567
[TBL] [Abstract][Full Text] [Related]
36. Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas.
McKeever PE; Smith BH; Taren JA; Wahl RL; Kornblith PL; Chronwall BM
Am J Pathol; 1987 May; 127(2):358-72. PubMed ID: 3555104
[TBL] [Abstract][Full Text] [Related]
37. CD46 represents a target for adenoviral gene therapy of malignant glioma.
Ulasov IV; Tyler MA; Zheng S; Han Y; Lesniak MS
Hum Gene Ther; 2006 May; 17(5):556-64. PubMed ID: 16716112
[TBL] [Abstract][Full Text] [Related]
38. A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy.
Leja J; Dzojic H; Gustafson E; Oberg K; Giandomenico V; Essand M
Clin Cancer Res; 2007 Apr; 13(8):2455-62. PubMed ID: 17438105
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
[TBL] [Abstract][Full Text] [Related]
40. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.
Abaza MS; Shaban F; Narayan RK; Atassi MZ
Anticancer Res; 1998; 18(2B):1333-40. PubMed ID: 9615812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
